ArticleslgStudy

chemistry

LEK-8842

LEK-8842 is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand LEK-8842 rather than just read about it. In short: LEK-8842, also known as N-methyl-N-(2-propynyl)lysergamide or as TRALA-01, is a serotonin receptor modulator of the lysergamide family related to the psychedelic drug LSD. The drug is described as showing serotonin 5-HT2 receptor partial agonistic activity and α-adrenergic receptor agonistic activity based on in-vitro tissue assays that included selective antagonist challenges.

LEK-8842 — main illustration
LEK-8842 — illustration

Key takeaways

  • LEK-8842 belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect LEK-8842 to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of LEK-8842 from memory before moving on to harder problems.

Reference excerpt

LEK-8842, also known as N-methyl-N-(2-propynyl)lysergamide or as TRALA-01, is a serotonin receptor modulator of the lysergamide family related to the psychedelic drug LSD. The drug is described as showing serotonin 5-HT2 receptor partial agonistic activity and α-adrenergic receptor agonistic activity based on in-vitro tissue assays that included selective antagonist challenges. Subsequently, it was found to be a potent partial agonist of the serotonin 5-HT2A and 5-HT2B receptors and to show affinity for the serotonin 5-HT2C receptor. LEK-8842 produces effects in animals including serotonin behavioral syndrome, hyperthermia, pressor effects, pupil dilation, and uterine contractions. The chemical synthesis of LEK-8842 has been described. Several analogues of LEK-8842 have been described, for instance LEK-8804 (N-(2-propynyl)lysergamide) among others. LEK-8842 was first described in the scientific literature by 1992. It was developed by the Slovenian pharmaceutical company LEK Pharmaceuticals. Subsequently, LEK-8842 was studied and patented by Matthias Liechti and Daniel Trachsel and colleagues in association with Mind Medicine (Definium Therapeutics) in 2023.

See also Substituted lysergamide LEK-8822 (9,10-dihydro-LEK-8842) LEK-8841 (2-bromo-LEK-8842) LEK-8829 (desoxy-LEK-8842) TRALA-12 (likely didehydro-LSD or DDH-LSD)

References

External links TRALA-01 - Isomer Design

Illustrations

LEK-8842 illustration

Worked examples

Example 1 — a first encounter with LEK-8842

Start with the simplest possible case. Write down what LEK-8842 claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to LEK-8842 before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about LEK-8842 ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of LEK-8842

In research
LEK-8842 appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses LEK-8842 in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
LEK-8842 is common in secondary-school and first-year university syllabi. It links to neighbouring topics 5-HT2A agonists, 5-HT2B agonists, Alpha-adrenergic agonists, so understanding it makes those chapters shorter.
In everyday life
Look for LEK-8842 outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “LEK-8842” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study LEK-8842 in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what LEK-8842 means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain LEK-8842 out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is LEK-8842 in simple terms?

LEK-8842, also known as N-methyl-N-(2-propynyl)lysergamide or as TRALA-01, is a serotonin receptor modulator of the lysergamide family related to the psychedelic drug LSD. The drug is described as showing serotonin 5-HT2 receptor partial agonistic activity and α-adrenergic receptor agonistic activi…

Why does LEK-8842 matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study LEK-8842?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on LEK-8842.

Tags

  • 5-HT2A agonists
  • 5-HT2B agonists
  • Alpha-adrenergic agonists
  • Carboxamides
  • Drugs not assigned an ATC code
  • Lysergamides
  • Methyl compounds
  • Propargyl compounds
  • Serotonin receptor modulators

Keep exploring